Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiyang Pharmaceutical, a subsidiary of the Liaoning Xiyang Group, is a Chinese pharmaceutical company primarily focused on the development and production of health supplements and traditional Chinese medicines (TCM). The company is most widely recognized for its extensive line of American Ginseng (Panax quinquefolius) products, marketed under the 'Xiyang' brand, which are used for fatigue and immune support. In addition to its TCM portfolio, the company manufactures various over-the-counter (OTC) generic chemical drugs. Xiyang Pharmaceutical operates large-scale manufacturing facilities in Liaoning province and maintains a significant commercial presence across mainland China. The company integrates raw material sourcing, processing, and distribution to ensure the quality of its botanical-based health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi Yang.